Variable | Pre-ACCESS | Post-ACCESS | Change, n (%) | P value |
---|---|---|---|---|
Number of cases, n | 367 | 365 | -2 (-1) | - |
Number of cases by priority, n (%) | <0.0001 | |||
P2 | 21 (6) | 1 (0.3) | -20 (-95) | |
P3 | 277 (75) | 167 (46) | -110 (-40) | |
P4 | 69 (19) | 197 (54) | +128 (+185) | |
Number of cases exceeding wait-time targets, n (%) | <0.0001 | |||
P2 | 13 (62) | 0 (0) | -13 (-100) | |
P3 | 92 (33) | 41 (25) | -51 (-55) | |
P4 | 2 (3) | 2 (1) | 0 (0) | |
Median wait-times by priority, days (range) | 0.94 | |||
P2 | 15 (2–29) | 9 (N/A) | -6 (-40) | |
P3 | 21 (0–90) | 15 (0–90) | -6 (-29) | |
P4 | 33 (6–92) | 22 (0–90) | -11 (-33) | |
Type of cancer, n (%) | 0.027 | |||
Breast | 104 (28) | 79 (22) | -25 (-24) | |
Colorectal | 119 (32) | 151 (41) | +32 (+27) | |
Hepatopancreatobiliary | 8 (2) | 18 (5) | +10 (+125) | |
Gastric | 10 (3) | 5 (1) | -5 (-50) | |
Endocrine | 100 (27) | 94 (26) | -6 (-6) | |
Lymph | 1 (0) | 0 (0) | -1 (-100) | |
Soft-tissue sarcoma | 6 (2) | 8 (2) | +2 (+33) | |
Skin carcinoma1 | 4 (1) | 2 (1) | -2 (-50) | |
Skin melanoma | 15 (4) | 7 (2) | -8 (-53) |